Lack of Pharmacodynamic Interaction of Silodosin, a Highly Selective α1a-Adrenoceptor Antagonist, With the Phosphodiesterase-5 Inhibitors Sildenafil and Tadalafil in Healthy Men-Reference-Cited by-同舟云学术

Lack of Pharmacodynamic Interaction of Silodosin, a Highly Selective α1a-Adrenoceptor Antagonist, With the Phosphodiesterase-5 Inhibitors Sildenafil and Tadalafil in Healthy Men

Published:2010-03 Issue:3 Volume:75 Page:520-525
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

MacDiarmid Scott A.,Hill Lawrence A.,Volinn Weining,Hoel Gary

Publisher

Elsevier BV

Subject

Urology

Reference15 articles.

1. Benign prostatic hyperplasia;Wei,2007

2. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty;Seftel;Int J Clin Pract,2008

3. Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH);Cambio;Ther Clin Risk Manag,2007

4. Alpha1-adrenoceptor subtypes and lower urinary tract symptoms;Schwinn;Int J Urol,2008

5. The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia;Lepor;Rev Urol,2006

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session;Current Drug Metabolism;2023-02

2. Evolving Role of Silodosin for the Treatment of Urological Disorders – A Narrative Review;Drug Design, Development and Therapy;2022-08

3. The efficacy and safety of silodosin-a review of literature;Pharmacy & Pharmacology International Journal;2021-12-16

4. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors;Uro;2021-07-05

5. Evaluation and Management of Erectile Dysfunction;Design and Implementation of the Modern Men’s Health Center;2020-10-16